Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000425 · ClinicalTrials.gov registry record · Phase 3
Toward Better Outcomes in Osteoarthritis
A Phase 3 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 3
- Development phase
- 900
- Enrollment target
NCT00000425: Completed Phase 3 study, sponsored by Stanford University.
NCT00000425 is a Phase 3 study that has completed, run by Stanford University. The registered enrollment target is 900 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000425, a Phase 3 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 900 participants
- Enrollment target
Study Summary
This study will determine if there is a difference between commonly used nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen (a pain-reliever that does not prevent inflammation) for treating knee pain in osteoarthritis (OA). The two main results we will look at are disease progression according to x-rays and disability over 3.5 years. Study participants with moderate knee OA and knee pain will continue taking their NSAID or stop taking their NSAID and start taking acetaminophen. Every 6 months we will send the participants questionnaires that ask about pain, medication use, and disability. We will take x-rays of the knees at the start of the study and again at the end of the study.
Interventions
- DRUG Acetaminophen
- DRUG Nonsteroidal anti-inflammatory drugs (NSAIDs)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 1996-07 |
| Est. Completion | 2001-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000425
The ClinicalTrials.gov registry entry for NCT00000425 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 900 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acetaminophen is the first listed.
NCT00000425 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000425 about?
NCT00000425 is a clinical study titled "Toward Better Outcomes in Osteoarthritis". This study will determine if there is a difference between commonly used nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen (a pain-reliever that does not prevent inflammation) for treating knee pain in osteoarthritis (OA). The two main results we will look at are disease progression ac...
What is the current status of trial NCT00000425?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 900 participants. The study started on 1996-07. Estimated completion is 2001-04.
What interventions are being tested in trial NCT00000425?
The interventions under investigation include: Acetaminophen (DRUG), Nonsteroidal anti-inflammatory drugs (NSAIDs) (DRUG).
Who is sponsoring clinical trial NCT00000425?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.